F.Biotechnology Dis.Fd.N-H1 PLN
LU2251237215
F.Biotechnology Dis.Fd.N-H1 PLN/ LU2251237215 /
| NAV14/05/2024 |
Chg.+0.0500 |
Type de rendement |
Focus sur l'investissement |
Société de fonds |
| 9.6900PLN |
+0.52% |
reinvestment |
Equity
Worldwide
|
Franklin Templeton ▶ |
Objectif d'investissement
The Fund aims to capital appreciation by investing principally in equity securities of biotechnology companies and discovery research firms mainly located in the US.
Opérations
| Type de rendement: |
reinvestment |
| Fonds Catégorie: |
Equity |
| Région de placement: |
Worldwide |
| Branche: |
Sector Biotechnology |
| Benchmark: |
NASDAQ Biotechnology Index |
| Début de l'exercice: |
01/07 |
| Dernière distribution: |
- |
| Banque dépositaire: |
J.P. Morgan SE, Niederlassung Luxemburg |
| Domicile: |
Luxembourg |
| Permission de distribution: |
Austria, Germany, Switzerland |
| Gestionnaire du fonds: |
Evan McCulloch, Wendy Lam, Akiva Felt |
| Actif net: |
1.63 Mrd.
USD
|
| Date de lancement: |
12/11/2020 |
| Focus de l'investissement: |
- |
Conditions
| Surtaxe d'émission: |
3.00% |
| Frais d'administration max.: |
2.25% |
| Investissement minimum: |
1,000.00 PLN |
| Deposit fees: |
0.14% |
| Frais de rachat: |
0.00% |
| Prospectus simplifié: |
Télécharger (Version imprimée) |
Société de fonds
| Société de fonds: |
Franklin Templeton |
| Adresse: |
Schottenring 16, 2.OG, 1010, Wien |
| Pays: |
Austria |
| Internet: |
www.franklintempleton.at
|
Actifs
| Stocks |
|
92.46% |
| Bonds |
|
1.90% |
| Autres |
|
5.64% |
Pays
| United States of America |
|
76.14% |
| Netherlands |
|
4.51% |
| United Kingdom |
|
4.08% |
| Denmark |
|
4.03% |
| Ireland |
|
2.67% |
| France |
|
1.10% |
| Cayman Islands |
|
0.52% |
| Canada |
|
0.50% |
| Bermuda |
|
0.45% |
| Germany |
|
0.36% |
| Autres |
|
5.64% |
Branches
| Pharma/Biotechnology |
|
87.69% |
| Healthcare services |
|
4.41% |
| Healthcare appliances |
|
0.36% |
| Autres |
|
7.54% |
